Sphenopalatine Ganglion Block to Treat Shoulder Pain After Laparoscopic Surgery

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective double blinded randomized pilot trial to evaluate the efficacy of phenopalatine ganglion block (SPGB) block to manage shoulder tip pain (STP) after laparoscopic surgery.

Patients undergoing laparoscopic surgery will be approached by a member of the research team and those found eligible for participating will be enrolled after signing an informed consent form.

Patients will be randomized to have the SPGB block with saline versus active drug which contains 10% lidocaine diluted to 5%.

The block will be performed , by an experienced member of the research team, and the patient will then be followed up by the investigator for any adverse events and levels of shoulder pain.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Any type of gynecologic, urologic, thoracic, bariatric and general surgical procedures

• Presence of post-operative STP, VAS > 4/10

• American Society of Anesthesiologists Class 1 - 3

Exclusion Criteria:

• American Society of Anesthesiologists Class 4 or 5.

• Allergy to lidocaine.

• Any patient who the PI feels will be unable to comply with all protocol related procedures

• Shoulder pain prior to surgery